The Brain and Hypothermia-From Aristotle to Targeted Temperature Management.
The Brain and Hypothermia-From Aristotle to Targeted Temperature Management.
复制标题
大脑和低温——从亚里士多德到有针对性的温度管理。
DOI:
10.1097/ccm.0000000000002182
复制
发表时间:
2017-02
影响因子:
8.8
通讯作者:
Jackson TC
中科院分区:
文献类型:
--
作者:
Kochanek PM;Jackson TC
Kochanek and Jackson306 www. ccmjournal. org February 2017• Volume 45• Number 2 its more aggressive use, discussed above, resurgence in the appreciation of mild TH and temperature regulation and its impact on acute brain injury emerged from the preclinical literature. The importance of “small differences” in temperature in impacting outcome in acute brain injury and the recognition that brain and core temperature were often somewhat different is often attributed to Busto et al (7). In that study, a 2 C temperature difference during global ischemia—from 36 C to 34 C—markedly reduced neuronal death in rat brain, whereas increasing temperature to 39 C increased neuronal death. That article impacted the field of experimental brain injury (8), and to this day, preclinical studies in experimental models of acute brain injury require temperature monitoring/control and often include brain temperature monitoring or surrogates such as temporalis muscle or tympanic membrane temperature. That report also challenged the notion that the benefits of TH were mediated solely by a reduction in energy demands below a critical threshold during ischemia—suggesting other undefined mechanisms. It was followed by studies in models of cardiac arrest (CA) in adult animals and of asphyxia in developing animals that set the stage for clinical trials showing benefit in both settings (9–14). The greatest efficacy of mild TH is seen in the treatment of birth asphyxia in term newborns with benefit versus standard of care on death, major disability, long-term outcome, and structural preservation on neuroimaging (15). It is also ironic that the greatest benefit of TH in acute brain injury is seen in infants, given the longstanding concerns in neonatology about the highly deleterious consequences of cold stress (16). Benefit of TH after asphyxia on mechanisms of special importance to the developing brain, such as apoptosis, has been suggested (17, 18). Also, nonshivering thermogenesis is the primary mechanism of heat production in infants versus adults, which may necessitate a distinct series of developmentally regulated biochemical responses or gene-regulatory events induced by cold stress in newborn patients. Contrasting the success seen with the use of mild TH in CA, despite early work showing the ability of TH to lower ICP, multicenter studies in TBI have failed to show benefit on long-term outcome. This included use in both adults and children in a variety of strategies (19–23). Relatively unique complications associated with the use of TH in TBI have included concerns with hemodynamic instability during rewarming, which may be deleterious if ICP is elevated and concerns with the many drugs used to treat TBI and toxicities from them given the inhibition of cytochrome P-450-mediated drug metabolism by TH (24–26). Some have suggested the need to use isolated brain cooling to achieve benefit without side effects in TBI (27). Alternatively, the mechanisms underlying secondary injury in TBI may simply be less favorably influenced by TH than those in CA and counterbalanced by greater side effects.